C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
195/1.12, 150/8.
C12Q 1/68 (2006.01) C07H 21/00 (2006.01)
Patent
CA 1338704
A method for diagnosing Alzheimer Disease or a predisposition to develop Alheimer Disease in an individual, by determining the presence of an alteration in the normal base sequence of the 24 base pairs appearing at the end of the APC coding sequence of the preAPC gene, or in the normal base sequence of the corresponding mRNA, in the DNA or RNA or such individual. The method detects the presence of a frameshift mutation in the preAPC gene postulated to result in the synthesis of the APC protein. Accumulation of APC protein in the brain is a phenomen of Alzheimer Disease. A variety of nucleic acid hybridization techniques are applicable to the determination of an alteration in the preAPC gene sequence of interest.
596313
Kamarck Michael E.
Rae Peter M. M.
Scangos George A.
Unterbeck Axel J.
Borden Ladner Gervais Llp
Molecular Therapeutics Inc.
LandOfFree
Molecular diagnosis of alzheimer disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Molecular diagnosis of alzheimer disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Molecular diagnosis of alzheimer disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1331503